Latest revenue
$20.8M
as of 2026-03-31
Latest net income
$-3.4M
as of 2026-03-31
Net margin
-16.5%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $25.2M
- Enterprise value
- $25.2M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $7.50
- 52-wk low
- $0.28
- Beta
- —
- Shares out
- 4.5M
5-year trend
About HBIO
Business description and risk factors will appear here once HBIO's latest filing is fully ingested.
Profitability
Gross margin
57.7%
0.9%Operating margin
-56.1%
750.7%Net margin
-65.5%
397.1%Return on equity
-412.8%
2331.9%Return on assets
-70.8%
622.9%Leverage
Debt / equity
4.83×
558.9%Long-term debt / equity
2.61×
Debt / assets
82.8%
95.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $20.8M | -4.7% | $-3.4M | +93.2% | -16.5% |
Q4 2025 2025-12-31 | $23.7M | -3.3% | $-2.8M | -15916.7% | -12.0% |
Q3 2025 2025-09-30 | $20.6M | -6.3% | $-1.2M | +74.4% | -6.0% |
Q2 2025 2025-06-30 | $20.4M | -11.5% | $-2.3M | +22.0% | -11.2% |
Q1 2025 2025-03-31 | $21.8M | -11.2% | $-50.3M | -972.4% | -231.2% |
Q4 2024 2024-12-31 | $24.6M | — | $18.0K | — | 0.1% |
Q3 2024 2024-09-30 | $22.0M | -13.4% | $-4.8M | -287.6% | -21.9% |
Q2 2024 2024-06-30 | $23.1M | -19.7% | $-2.9M | -717.6% | -12.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Laboratory Analytical Instruments · SIC 3826
Your notes
Keep private notes on HBIO — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$202.4K
Insider selling
$0
Net activity
+$202.4K
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns HBIO
Institutional value
$0
Total shares held
30
Distinct holders
1
-63 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Financial Connections Group, Inc. | 30 | $0 | -270 (-90.0%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once HBIO's latest filing finishes processing.